Cargando…
Clinical considerations of lipid target and goal in dyslipidemia control
Autores principales: | Wu, Na-Qiong, Li, Jian-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643590/ https://www.ncbi.nlm.nih.gov/pubmed/29063017 http://dx.doi.org/10.1016/j.cdtm.2016.05.002 |
Ejemplares similares
-
Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals
por: Saito, Yasushi
Publicado: (2009) -
Progress of research on dyslipidemia accompanied by nephrotic syndrome
por: Tao, Min, et al.
Publicado: (2020) -
Amendment of the low-density lipoprotein cholesterol target in the ‘Chinese Guidelines for the Prevention and Treatment of Adult Dyslipidemia’: Opinion
por: Zhao, Shui-Ping
Publicado: (2016) -
Effect of alirocumab dose increase on LDL lowering and lipid goal attainment in patients with dyslipidemia
por: Kastelein, John J.P., et al.
Publicado: (2017) -
Sustainable development goal 2: Improved targets and indicators for agriculture and food security
por: Gil, Juliana Dias Bernardes, et al.
Publicado: (2018)